Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

FE ≤ 200 μg/g did not associate with laboratory markers of hepatobiliary function, pancreatic amylase, SSc disease duration, or antibody profile (Table 2).Laboratory and clinical characteristics of patients with and without pathological levels of fecal elastaseALT (U/L)AST (U/L)GGT (U/L)ALP (U/L)Pancreatic amylase (U/L)Calcium (mmol/l)Magnesium (mmol/l)Albumin (g/l)Prealbumin (g/l)Vitamin D3 (nmol/l)Disease duration (years)Age (years)ACA (n)ATA (n)ARA (n)FE ≤ 200 μg/g (n = 6)25 (16 to 41)29 (22, 40)55 (22, 156)71 (71,881.2)24 (22, 32)2.4 (2.3, 2.5)0.93 (0.77, 1.1)40 (37, 42)0.33 (0.19, 0.36)48 (29, 65)5 (1, 15)70 (57, 76)111FE > 200 μg/g (n = 106)19 (14, 24)24 (21, 29)25 (17, 0.46)71 (52, 81)25 (18, 0.38)2.3 (2.3, 2.4)0.82 (0.77, 0.86)39 (36, 41)0.25 (0.2, 0.3)70 (45, 78)7(3, 15)60 (61, 69)38199Systemic sclerosis patients with pathological FE testing did not differ compared to other patients with regard to laboratory markers of liver function and malnutrition, disease duration, age, and antibody profile. p > 0.05 for all variables when comparing patients with FE ≤ 200 μg/g to patients with FE > 200 μg/g.

Source: Clinical characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were characterized regarding SSc manifestations including gastrointestinal and hepatobiliary function, by use of laboratory and clinical examinations.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Exocrine pancreatic function is preserved in systemic sclerosis

Study design awaiting verification · Arthritis Research & Therapy · 2019

Original publication title

Exocrine pancreatic function is preserved in systemic sclerosis

Gracijela Bozovic; Rille Pullerits; Arne Ståhl; Kristina Ydström; Daniel Wenger; Jan Marsal; Pontus Thulin; Kristofer Andréasson

© The Author(s). 2019

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In this study encompassing 112 consecutive SSc patients and 52 matched control subjects, we were unable to associate systemic sclerosis with clinically significant exocrine pancreatic dysfunction.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Systemic sclerosis (SSc) has been suggested to cause exocrine pancreatic dysfunction. However, a case-control-based autopsy study failed to associate systemic sclerosis with any pancreatic histopathology. The primary objective of this study was to examine the exocrine pancreatic function in consecutive SSc patients in relation to an age: and sex-matched control group. A secondary objective was to relate exocrine pancreatic function to radiological, laboratory, and clinical SSc characteristics.

Source: Background

Abstract: What methods does the paper describe?

One hundred twelve consecutive patients fulfilling the 2013 American Congress of Rheumatology/European League Against Rheumatism criteria for SSc and 52 control subjects were matched for sex and age. Exocrine pancreatic function was assessed by ELISA-based measurement of fecal elastase, and levels ≤ 200 μg/g were considered pathological, i.e., representing exocrine pancreatic insufficiency. Patients were characterized regarding SSc manifestations including gastrointestinal and hepatobiliary function, by use of laboratory and clinical examinations. Pancreas parenchyma characteristics were evaluated by high-resolution computer tomography (HRCT).

Source: Methods

Abstract: Electronic supplementary material

The online version of this article (10.1186/s13075-019-1840-z) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material

Abstract: Results

A similar proportion of subjects exhibited pathological levels of fecal elastase among SSc patients (6/112; 5.4%) and control subjects (3/52; 5.8%). Patients with fecal elastase ≤ 200 μg/g did not differ from other SSc patients with respect to laboratory and clinical characteristics, including malnutrition. SSc subjects with low levels of fecal elastase displayed significantly lower pancreas attenuation on HRCT examinations compared to the control subjects.

Source: Results

Abstract: Conclusions

In this study encompassing 112 consecutive SSc patients and 52 matched control subjects, we were unable to associate systemic sclerosis with clinically significant exocrine pancreatic dysfunction.

Source: Conclusions
Authors’ abstract

Background

Systemic sclerosis (SSc) has been suggested to cause exocrine pancreatic dysfunction. However, a case-control-based autopsy study failed to associate systemic sclerosis with any pancreatic histopathology. The primary objective of this study was to examine the exocrine pancreatic function in consecutive SSc patients in relation to an age: and sex-matched control group. A secondary objective was to relate exocrine pancreatic function to radiological, laboratory, and clinical SSc characteristics.

Methods

One hundred twelve consecutive patients fulfilling the 2013 American Congress of Rheumatology/European League Against Rheumatism criteria for SSc and 52 control subjects were matched for sex and age. Exocrine pancreatic function was assessed by ELISA-based measurement of fecal elastase, and levels ≤ 200 μg/g were considered pathological, i.e., representing exocrine pancreatic insufficiency. Patients were characterized regarding SSc manifestations including gastrointestinal and hepatobiliary function, by use of laboratory and clinical examinations. Pancreas parenchyma characteristics were evaluated by high-resolution computer tomography (HRCT).

Results

A similar proportion of subjects exhibited pathological levels of fecal elastase among SSc patients (6/112; 5.4%) and control subjects (3/52; 5.8%). Patients with fecal elastase ≤ 200 μg/g did not differ from other SSc patients with respect to laboratory and clinical characteristics, including malnutrition. SSc subjects with low levels of fecal elastase displayed significantly lower pancreas attenuation on HRCT examinations compared to the control subjects.

Conclusions

In this study encompassing 112 consecutive SSc patients and 52 matched control subjects, we were unable to associate systemic sclerosis with clinically significant exocrine pancreatic dysfunction.

Electronic supplementary material

The online version of this article (10.1186/s13075-019-1840-z) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Exocrine pancreatic function is preserved in systemic sclerosis

Gracijela Bozovic; Rille Pullerits; Arne Ståhl; Kristina Ydström; Daniel Wenger; Jan Marsal; Pontus Thulin; Kristofer Andréasson

Arthritis Research & Therapy · 2019

© The Author(s). 2019https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.http://dx.doi.org/10.13039/501100007687Svenska LäkaresällskapetSLS-595121Andréasson Kristofer Magnus Bergvalls Stiftelse (SE)2016-01820Andréasson Kristofer http://dx.doi.org/10.13039/501100007949ReumatikerförbundetR-478421Pullerits Rille Anna-Greta Crafoord Foundation20162008Andréasson Kristofer

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T18:45:28.576117+00:00

DOI: 10.1186/s13075-019-1840-z · PMC6373050